Article metrics

Download PDFPDF

DNA vaccine VGX-3100 with electroporation induces regression of cervical intraepithelial neoplasia 2/3 and clears HPV infection with robust T cell responses: results of a randomized, double-blind, placebo-controlled Phase II trial

 

Online download statistics by month:

Online download statistics by month: December 2019 to January 2024

AbstractFullPdf
Dec 2019031
Jan 2020031
Feb 2020071
Apr 2020030
May 2020050
Jun 2020010
Jul 2020021
Sep 2020060
Oct 2020010
Nov 2020020
Dec 2020010
Jan 2021060
Feb 20210112
Mar 2021042
Apr 2021061
May 2021060
Jun 20210152
Jul 2021030
Aug 2021092
Sep 2021031
Oct 2021055
Nov 2021084
Dec 20210121
Jan 2022050
Feb 2022020
Mar 2022031
May 2022083
Jun 2022051
Jul 2022010
Aug 2022050
Sep 2022071
Oct 2022040
Nov 2022030
Dec 2022050
Jan 2023040
Feb 2023010
Mar 2023040
Apr 2023061
May 2023020
Jun 2023041
Jul 2023021
Sep 2023060
Oct 20230161
Nov 2023062
Dec 2023031
Jan 2024020
Total022637